Zimmer Biomet Holdings (ZBH) Net Cash Flow Growth (1y) (2010 - 2026)
Powered by 
Analysis
Zimmer Biomet Holdings (ZBH) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | -562.77% |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | -9.88% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 83.30% |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | 2,827.78% |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | -395.56% |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | 168.38% |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | -593.75% |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | -103.49% |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | -54.17% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 98.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.33% |
| Mar 31, 2026 | -119.81% |
| Dec 31, 2025 | -2,651.37% |
| Sep 30, 2025 | 432.18% |
| Jun 30, 2025 | -2,861.97% |
| Mar 31, 2025 | 5,083.63% |
| Dec 31, 2024 | -121.94% |
| Sep 30, 2024 | 678.75% |
| Jun 30, 2024 | 763.04% |
| Mar 31, 2024 | 64.67% |
| Dec 31, 2023 | 163.95% |
| Sep 30, 2023 | -113.98% |
| Jun 30, 2023 | 89.47% |
| Mar 31, 2023 | -143.14% |
| Dec 31, 2022 | 58.91% |
| Sep 30, 2022 | 250.35% |
| Jun 30, 2022 | -114.98% |
| Mar 31, 2022 | 239.55% |
| Dec 31, 2021 | -73.48% |
| Sep 30, 2021 | -146.18% |